Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 8/22/2023China Expands Reimbursement of Rare Disease Drugs to Improve Access: N...
  • 8/22/2023CDE Solicits Comments on Bioequivalence Study Guidelines of Six Generi...
  • 8/22/2023Simcere, MabTech Inks Collaborative Agreement for CMAB009 in Mainland ...
  • 8/22/2023CSPC, Insilico and XtalPi Sign Strategic Collaboration on AI Innovativ...
  • 8/21/2023NHC: China's Health Literacy Improved in 2022 (Free)
  • 8/21/2023Moderna and CARsgen Join Forces to Combine mRNA Cancer Vaccine with CA...
  • 8/18/2023Recent Executive Moves
  • 8/18/2023Drug R&D and Product Registration News Digest August 2023 (3)
  • 8/18/2023NHSA Publicizes the List of Drugs Passing Preliminary Form Evaluation ...
  • 8/17/2023NMPA Revises the Information Standard System for Drug Regulatory Digit...
  • 8/17/2023NMPA Issues the List of Reference Formulations for GQCE Studies (71st ...
  • 8/17/2023NMPA Announces Package Insert Revision of Three Drug Products
  • 8/16/2023Biocytogen Pharma Announces Opening of Waltham, MA Facility
  • 8/15/2023NHC Releases Q&A Document to Highlight/Clarify Focused Areas of Health...
  • 8/15/2023Kingworld to Acquire Another 2.08% Stake of Japan's Taiko Pharma
  • 8/15/2023Hengrui Licenses New Asthma Drug to One Bio in $1B Licensing Deal
  • 8/15/2023Aurisco Pharma's Plant in Yangzhou Passes USFDA Inspection (Free)
  • 8/14/2023China's Medicine and Health Product Trade Down in H1/2023 as World Mov...
  • 8/14/2023The Chinese Market for CAR-T Therapies to See Sharp Growth Before 2030
  • 8/14/2023China Introduces New Policy to Boost Foreign Investment, Highlighting ...
  • 8/14/2023Arcutis and Huadong Strike Licensing Deal for Topical Roflumilast in G...
  • 8/11/2023Drug R&D and Product Registration News Digest August 2023 (2)
  • 8/11/2023Recent Executive Moves
  • 8/11/2023China's COVID Status and Its New Round of COVID-19 Vaccination Plan fo...
  • 8/11/2023Antengene Enters into Commercialization Partnership with Hansoh for FI...
  • 8/10/2023Multiple Domestic Pharma Cos Hold Off Their IPO Plans in the Wake of A...
  • 8/10/2023Hengrui Denies Rumors of Being Targeted in Anti-Corruption Campaign a...
  • 8/9/2023Novartis Responds to Hospital's Staff Dismissal Recommendation Amid Ch...
  • 8/9/2023China Intensifies Efforts to Combat Healthcare Corruption
  • 8/8/2023Fosun Pharma Begins First Commercial Sale of Palatin's HSDD in China (Free)
  • Page:30/33 Total number of articles:961: [First][<<] [28] [29] [30] [31] [32] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group